Latest News

Oslo, Norway, 14 June 2021: Reference is made to the stock exchange release by Photocure ASA ("Photocure" or the "Company") published on 7 June 2021 regarding a share capital increase following the exercise of share options.

Oslo, Norway, 8 June 2020: Reference is made to the stock exchange release by Photocure ASA ("Photocure" or the "Company") published on 7 June 2021 regarding initiation of a share buyback program.

Oslo, Norway, 9 June 2021: Reference is made to the stock exchange release by Photocure ASA ("Photocure" or the "Company") published on 7 June 2021 regarding exercise of share options.

Oslo, Norway, 7 June 2021: Participants in Photocure ASA's ("Photocure" or the "Company") share option program have on 7 June 2021 exercised a total of 98,251 options distributed as follows:

• 9,501 options exercised according to the option program for 2017 at a strike price of NOK 38.06; and
• 88,750 options exercised according to the option program for 2019 at a strike price of NOK 50.72

Oslo, Norway, June 7, 2021

Photocure ASA ("Photocure" or the "Company") has decided to initiate a buyback of up to 50,000 of its own shares for a total maximum amount of NOK 12,500,000. The buyback program may be carried out in the period from this announcement and until June 30, 2021.

Press Release – Oslo, Norway, 27 May 2021, Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces that President and Chief Executive Officer, Daniel Schneider and Chief Financial Officer, Erik Dahl are scheduled to present corporate overviews at two upcoming institutional investor conferences in June.

Oslo, Norway, 20 May 2021: Photocure ASA (OSE: PHO), held its annual general meeting on 20 May 2021 at 17:00 hours (CET).

Oslo, Norway, 19 May 2021: Reference is made to the stock exchange release by Photocure ASA ("Photocure" or the "Company") (OSE: PHO) published on 15 September 2021 regarding 370,000 share options granted conditionally.

Oslo, Norway, 19 May 2021: Photocure ASA (OSE:PHO), the Bladder Cancer Company, today reported Hexvix^®/Cysview^® revenues of NOK 81.6 million in the first quarter of 2021 (Q1 2020: NOK 54.4 million), and EBITDA of NOK 18.1 million (NOK -4.8 million), following the continued successful launch in markets previously operated by Ipsen Pharma SAS. The third Covid-19 wave impacted operations in the quarter, but a strong March performance indicates the environment is improving.

Oslo, Norway, May 18, 2021: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that notification was given to its partner and exclusive distributor, Genotests SpA by the Instituto de Salud Pública de Chile that the Marketing Authorization Application (“MAA”) for Hexvix^® has been accepted for regulatory review.

Oslo, Norway, 14 May 2021: Photocure ASA (OSE:PHO) - the Annual General Meeting (AGM) at will be held 20 May 17:00 CEST. The AGM will be live streamed and Dan Schneider, President & Chief Executive Officer, will provide a general company update.

Oslo, Norway, 13 May 2021: Photocure ASA (Photocure, PHO: OSE) will announce the first quarter 2021 financial results on Wednesday 19 May 2021 at 07:00 CET and invites investors, analysts and the media to a presentation at 14:00 CET the same day.

Oslo, Norway, 12 May 2020: Photocure ASA ("Photocure" or the "Company") has on 12 May 2021 repurchased a total of 5,344 own shares. The shares were restricted shares and are repurchased pursuant to the terms of the Company's long term incentive program and due to the resignment of one of the former participants in the incentive program.

Press release – Oslo, Norway, April 30, 2021: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of its sustainability (ESG) report for 2020, renewing its commitment to transparency, corporate governance principles, sustainability and business ethics.
As a result of this commitment, Photocure has also recently become a signatory of the United Nations Global Compact.

Oslo, Norway, 29 April 2021: Photocure ASA (OSE: PHO), calls for the annual general meeting (webcast) of PHO to be held at Advokatfirmaet Selmer AS' premises in Tjuvholmen allé 1, 0252 Oslo, Norway on 20 May 2021 at 17:00 hours (CET).

Oslo, Norway, 29 April 2021: The Board of Directors of Photocure ASA has approved the Annual Report 2020.

Oslo, Norway, April 27, 2021: Radforsk Investeringsstiftelse, a legal person closely associated with a person discharging managerial responsibilities in Photocure ASA has notified the company of a pledge of shares in Photocure ASA.